Please login to the form below
business model
This page shows the latest business model news and features for those working in and with pharma, biotech and healthcare.
Amgen and Synaffix sign licensing agreement worth up to $2bn
The business model of Synaffix is target-specific technology out-licensing, shown through its existing deals with ADC Therapeutics, Mersana Therapeutics, Shanghai Miracogen, Innovent Biologics, ProfoundBio, Kyowa Kirin, Genmab, Macrogenics and
Latest news
-
Born strategic – Why great strategists are both born and made
Professor Brian D Smith is an authority on the pharmaceutical industry and works at SDA Bocconi University and Hertfordshire Business School. ... Most firms use short, standardised strategy courses. To make it worse, those courses are often neither
-
Moderna deal to build state-of-the-art manufacturing plant bolsters Canada’s vaccine production
We believe that this innovative business model will have global impact and implications.”.
-
MHRA outlines two-year delivery plan with ‘patient first’ focus
The delivery of these plans is underpinned by the creation of a new business model that will provide a ‘financially sustainable future’ for the MHRA. ... According to the MHRA, this new model will meet the expectations of patients, healthcare
-
Pfizer's basic instincts
Business model evolution can’t defy strategic gravity. I read the recent news announcing Pfizer’s new logo with interest. ... being inevitable and a sort of inescapable ‘gravity’ of business model evolution.
-
Bayer's drop of the future
Flipping through the pages of ‘Darwin’s Medicine’, I am reminded that I saw – and see – the challenge of business model design as one of capability acquisition. ... And in Bayer/One Drop we see a holobiont business model designed to bring
More from news
Approximately 1 fully matching, plus 242 partially matching documents found.
Latest Intelligence
-
Envisioning a healthier every day, for every woman
Creating a sustainable business that serves a critical need. As a new company, we have integrated our purpose and our Environmental, Social and Governance (ESG) principles into the core of our ... Environment: Her planet. Elevate our ambition to achieve
-
Building a brighter future with patient support programmes
lupus. The agency is convinced it will demonstrate a higher level of efficacy and create a strong business model based on its data science and health economic evaluation.
-
How Resonant’s innovation and creativity resolve healthcare communications challenges
It’s also about the values we hold, which are a big driver within each business. ... And, with a boutique style business model, client experience is always front of mind.
-
Lessons from a pandemic – holistic strategy in the time of coronavirus
Applying this to our business model for pharmaceuticals, we can see that although there are differences in the standard of care, these are shrinking. ... The financial commitment from this organisational inefficiency would kill any business.
-
The decentralisation of clinical trials is a key catalyst for innovation in artificial intelligence
However, it is the more vague, general sense of a machine being able to do something previously thought to be an exclusively human activity that is gaining practical acceptance by business ... A key sustainer of the relationship between data scientist
More from intelligence
Approximately 0 fully matching, plus 54 partially matching documents found.
Latest appointments
-
Neurocentrx appoints two members to the board
Brooksby brings experience in business and growth strategy across the healthcare sector having held senior global positions at Pfizer, Sanofi and Wellcome - now GSK. ... Brooksby said: “My focus is to accelerate the business model and drive commercial
-
Rainer Boehm and Hervé Hoppenot join Cellectics board
Boehm spent 29 years serving Novartis working in various senior management, marketing, sales, and medical affairs roles, and his expertise spans from leadership and development to business model solutions. ... oncology and head of the US oncology
-
Novocure’s chief commercial officer to step down
During his tenure, Peter developed our commercial business model, launched the Optune brand and drove eight consecutive quarters of active patient and revenue growth after the presentation of our EF-14
-
Galenica Group strengthens management team
We opted for these variant because of the excellent knowledge Stefan Schulze brings to further developing the business model of Vifor Pharma.”. ... Santé. Burkhard joined the Galenica Group in 1996 as corporate controller of Galenica, taking
-
Moderna Therapeutics appoints chief business officer
Saqib Islam brings experience from Alexion Pharmaceuticals. Cambridge, Massachusetts-based Moderna Therapeutics has appointed Saqib Islam as its new chief business officer from 9 May. ... Islam said: “Already a clinical stage company, Moderna has
More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.
Latest from PMHub
-
Pharma, Technology, and Healthcare in the New Normal
He also explores subjects such as patient-centricity, how Pharma’s business model will change in the future, and the role of digital technologies in clinical trials and medical education.
-
What does the future hold for clinical trial recruitment?
For the business model of the database to prove itself, it comes down to the quality and speed of finding those trial participants.
-
Improving healthcare for rare disease patients
With a relatively low number of individuals affected, the normal pharmaceutical business model doesn’t work when it comes to rare disease.
-
Unpacking rare diseases in the first edition of Delta magazine
disease drug development and launch requires a unique business model.
-
Unpacking rare diseases in the first edition of Delta magazine
disease drug development and launch requires a unique business model.
More from PMHub
Approximately 1 fully matching, plus 24 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- AstraZeneca joins UK pilot evaluating AI-based lung cancer diagnosis system
- Eli Lilly’s Alzheimer’s drug denied FDA accelerated approval
- EU to revise pharmaceuticals law amid antibiotic shortages
- Medical Affairs: centre-stage in scientific engagement strategies
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Tidepool’s automated insulin dosing app for type 1 diabetes gets FDA approval
- UK to introduce new regulatory framework for point of care manufacturing
- Navigating the patient experience to improve retention of clinical trial participants
- Europe’s cancer community publishes new report on transforming patient care
- Alzheimer’s Research UK welcomes government’s pledge to tackle dementia crisis
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- EU to revise pharmaceuticals law amid antibiotic shortages
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Why everyone in pharma is bending over backwards to be agile
PMHub
nzyme
The nzyme group focuses on the three fundamentals that enable full patient access - Education, Access & Activation. Our specialist...
Latest intelligence
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
- Report gives insights to address gaps in HCP engagement
- How does Pharma-HCP engagement need to evolve in today's digital landscape?...
